Thanks to the rich biodiversity and special conditions of marine ecosystems, the ocean can provide an astounding variety of molecules with unique features and unmatched complexity.
Marine invertebrates (like soft corals, sponges and sea anemones) are becoming widely recognised as a source of bioactive compounds and biomaterials, with diverse commercial applications, from cosmetics and medical drugs to bioremediation. The main bottleneck that remains is the sourcing of marine biodiversity. TASCMAR will develop innovative technologies for the cultivation of invertebrates and their associated microorganisms to respond to a key challenge set by the EU Blue Growth Strategy: to make discovering and commercialising marine-derived molecules more sustainable, efficient and environmentally friendly. See the EU Blue Growth infographic